Chrysantis' EZ Eyes accepted as NDI
Chrysantis is ready to start selling EZ Eyes to dietary supplement makers following the FDA's acceptance of the marigold-derived natural zeaxanthin as a new dietary ingredient (NDI), reports Jess Halliday.
Archives for June 29, 2005
Ginger studied for potential to help stop vomiting from chemotherapy
US scientists will investigate whether ginger can help cancer patients avoid nausea and vomiting from chemotherapy.
Peptide nutraceutical reduces build-up of Alzheimer's plaques
A mixture of peptides derived from colostrum could help slow the progression of Alzheimer's disease by reducing the build-up of beta amyloid, a toxic protein that accumulates in the brains of Alzheimer's sufferers, reports Dominique Patton.
Could mistletoe prevent bladder cancer recurrence?
A new study into the ability of mistletoe to decrease the reoccurrence of tumors in bladder cancer patients seems to show that it is as effective as the most common conventional approach, but without the side effects. But scientific opinion is divided...
Phytolab invests million in new analysis technology
German plant extracts group Martin Bauer has invested more than €1 million in new technology for its research centre PhytoLab and built a new 1600 square metre laboratory building as part of the expansion, writes Dominique Patton.
Potato compounds could lower blood pressure levels
UK scientists have identified previously unknown compounds in the potato that are also found in a herbal used to lower blood pressure, reports Dominique Patton.
Sweet news for plant bakers
A new invert syrup from British Sugar offers convenience and flexibility benefits for plant bakers.Invasweet was developed to meet the bakery...
Pharming licenses lactoferrin production tech to NZ group
Pharming has licensed rights to its protein production technology, based on the use of transgenic animals, to AgResearch, the largest government owned research organisation in New Zealand, reports Phil Taylor.